Recently, listed companies in various fields of medical equipment in China have disclosed their 2015 annual performance report. The following is an inventory of you, and how much they have earned in 2015.
Diving medical
In 2015, Yuyue Medical achieved a total operating income of 2.123 billion yuan, a year-on-year increase of 26.37%; net profit of 369 million yuan, an increase of 24.23%.
The Express reported that the performance of the e-commerce platform has grown rapidly, and the strategic products such as electronic sphygmomanometers , atomizers, blood glucose meters and test strips have grown rapidly, and the core product oxygen generators have maintained a steady and rapid growth rate. In addition, a number of new products such as sleep ventilators, medical electronic sphygmomanometers, vacuum blood collection tubes, and indwelling needles have been introduced.
Lepu Medical
In 2015, Lepu Medical achieved operating income of 2.776 billion yuan, an increase of 66.42%, operating profit of 685 million yuan, an increase of 32.7%, total profit of 702 million yuan, an increase of 30.96%.
According to the Express, the company's medical device segment continued to grow. The revenue and profit increased steadily compared with the same period of the previous year. The original varieties of Lepu Pharmaceutical in the pharmaceutical sector grew rapidly, and the new Donggang Pharmaceutical was included in the consolidation scope. The revenue and profit increased significantly compared to the same period last year.
Yangpu Medical
The company's operating income last year was 547 million yuan, an increase of 18.38% year-on-year; net profit was 41 million yuan, down 22.13% year-on-year.
The Express pointed out that the year-on-year decrease in profit was due to the company entering the health management field in 2014 and entering the medical service field in 2015. Currently, the two businesses are still in the early stage of investment. In 2015, the health product business and medical service business spent a total of 6.03 million. yuan. In addition, the company established a US subsidiary in July 2014 to introduce overseas innovations and strengthen overseas sales of existing products. During the reporting period, US subsidiaries spent approximately RMB 6 million.
David Medical
In 2015, Dawei Medical achieved operating income of 219 million yuan, down 3.41% year-on-year; net profit was 44.93 million yuan, down 16.18% year-on-year.
The decrease in net profit was mainly due to the fact that the wholly-owned subsidiary Ningbo Weier Kaidi Medical Devices Co., Ltd. obtained the medical device registration certificate for the product in May 2015, and has started to put into normal operation. The management expenses and sales expenses incurred during the reporting period increased significantly and The decline in bank deposit interest rates has led to a decrease in bank interest income.
Sanxin Medical
The company's operating income last year was 312 million yuan, a year-on-year decrease of 3.21%. The net profit was 5,187.64 million yuan, a year-on-year increase of 6.71%.
Sanxin Medical's main products include four series of “blood purificationâ€, “indwelling cathetersâ€, “injection†and “infusion and blood transfusionâ€.
Sannuo
In FY2015, Sanno achieved operating income of 646 million yuan, a year-on-year increase of 18.46%. Net profit was 143 million yuan, a year-on-year decrease of 27.48%.
As the company increased the hospital market development and R&D investment during the reporting period, the sales expenses and R&D expenses increased. At the same time, due to the company's participation in overseas assets, bidding and acquisition of the subject, the agency fees increased, resulting in the company's profit level compared with the same period last year. Reduced.
Kelly
Kelly's operating income last year was 463 million yuan, a year-on-year increase of 108%; net profit was 121 million yuan, a year-on-year increase of 95%.
Libang Instrument
In 2015, the company expects to achieve operating income of 550 million yuan, an increase of 5.23%; operating profit is estimated to be 65.5 million yuan, an increase of 742.66%; total profit is expected to be 108.77 million yuan, an increase of 783.89%.
Express said that with the strengthening of the company's marketing network construction, operating income maintained steady growth.
Organic stevia extract is a natural sweetener extracted from the pure leaves of the stevia plant. Stevia extract is a natural sweetener and a natural substitute for artificial sweeteners such as aspartame, saccharin, and sucralose. They are all zero-calorie sweeteners, but stevia is a natural source and has no industrial residues. The main components of stevia extract are stevioside and rebaudioside A. The sweetness is high, and the sweetness is 90-450 times of sucrose / edible sugar. It is ideal for patients with diabetes, hypertension, dental caries, and arteriosclerosis.
Stevia Extract,Organic Stevia Sugar,Organic Stevia Extract,Stevia Extract Powder
Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayince.com